Hope After an Alzheimer’s Diagnosis: Teri and Gail’s Story of Resilience

After being diagnosed with mild cognitive impairment and later early Alzheimer’s disease, Gail Youngdale feared what the future might hold. She’d seen the devastating effects of the disease on her own mother years ago. Seeking options, she enrolled in a landmark clinical trial for a therapy designed to remove toxic amyloid plaques, a hallmark of Alzheimer’s disease, from the brain. 

Her daughter, Teri, served as her clinical trial study partner—attending every appointment, supporting Gail through the process, and learning as much as she could about Alzheimer’s and her own genetic risk of developing the disease.

 “After she was diagnosed with Alzheimer’s, I saw the fighter in my mom come out. She inspired me to take my own brain health seriously,” Teri said. 

Today, Gail continues treatment with the now FDA-approved medication for early Alzheimer’s disease and has been able to maintain her independence and quality of life. She even found a second chance at love after reconnecting with her high school sweetheart.

Teri has become a passionate advocate for Alzheimer’s awareness and early diagnosis. She speaks across North Texas, sharing Gail’s journey and encouraging families to seek answers at the first signs of cognitive decline, when emerging treatments and interventions may be most effective. She’s also committed to a brain-healthy lifestyle–prioritizing a healthy diet, exercise, social engagement, and quality sleep–and advocating for continued research to unlock better treatments, earlier detection methods, and ultimately a cure. 

Through their shared story, Gail and Teri highlight the importance of research, early intervention, and hope for individuals and families affected by Alzheimer’s disease. 

“For our family, her diagnosis wasn’t the end of her story,” Teri said. “It’s been a reminder to appreciate every moment and to focus on what is still possible.”